BioSpace News Archive

Business

Zogenix Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Resubmitted NDA for FINTEPLA® for the treatment of Dravet syndrome

November 7, 2019
·
13 min read
Deals

Sientra Announces Acquisition of the Independently Operated OPUS® Breast Implant Manufacturing Operation from Lubrizol Life Science

Vertical integration critical next step in advancing Sientra’s strategic objectives

November 7, 2019
·
10 min read
Business

Pacific Biosciences of California, Inc. Announces Third Quarter 2019 Financial Results

Pacific Biosciences of California, Inc. announced financial results for its third quarter ended September 30, 2019..

November 7, 2019
·
7 min read
Business

Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs

Completed Strategic Review and Announced Refocusing of Resources on Immuno-inflammatory Development Pipeline

November 7, 2019
·
13 min read
Business

Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

Arcturus Therapeutics Holdings Inc. reported its financial results for the three- and nine-month periods ended September 30, 2019 and provided a corporate update.

November 7, 2019
·
7 min read
Business

Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2019 Financial Results

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, reported financial results for the third quarter ended September 30, 2019 and provided a corporate update.

November 7, 2019
·
9 min read
Business

Flexion Therapeutics Reports Third-Quarter 2019 Financial Results and Recent Business Highlights

Company reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $21.8 million in Q3 representing 29% growth over Q2

November 7, 2019
·
15 min read
Business

Capricor Therapeutics Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Update

Provides Update on End of Phase Type-B Meeting with FDA

November 7, 2019
·
10 min read
Business

GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results

Global Blood Therapeutics, Inc. reported recent business progress and financial results for the third quarter ended September 30, 2019..

November 7, 2019
·
9 min read
Business

Misonix Fiscal 2020 First Quarter Record Quarterly Product Revenue Of $11.1 Million

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, reported financial results for the fiscal 2020 first quarter ended September 30, 2019 as summarized below:

November 7, 2019
·
14 min read